Health Conditions

References

1. Fankhauser MP, Freeman MP. Bipolar Disorder. In: Dipiro JT, et al. Pharmacotherapy: A Pathophysiologic Approach. 6th ed., 1257-1284.

2. Borovicka MC, Love RC. Mood Disorders II: Bipolar Disorder. In: Koda-Kimble MA, et al. Applied Therapeutics: The Clinical Use of Drugs. 8th ed., 80-1 to 80-19.

3. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 2005 Jun;62(6):617-27.

4. National Institutes of Mental Health. Bipolar Disorder. National Institutes of Health. Updated January 2007; http://www.nimh.nih.gov/healthinformation/bipolarmenu.cfm. Accessed March 2007 and February 2008.

5. Muller-Oerlinghausen B, et al. (2002). Bipolar disorder. Lancet, 359(9302): 241-247.

6. Perugi G, et al. (July 2001). Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series. Pharmacopsychiatry. 34(4): 137-41.

7. MDF The Bipolar Organisation. Accessed March 2007 and February 2008. http://www.mdf.org.uk/

8. American Psychiatric Association: Bipolar Disorders. Accessed March 2007 and February 2008. http://www.healthyminds.org/multimedia/bipolardisorder.pdf

9. Clinicaltrials.gov. Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Available at: http://www.clinicaltrials.gov/ct/show/NCT00012558?order=1. Accessed March 2007 and February 2008.

10. Mayoclinc.com. Bipolar Disorder. Updated Jan 4 2008. http://www.mayoclinic.com/health/bipolar-disorder/DS00356#. Accessed February 2008.

11. Clinicaltrials.gov. Comparing the Safety and Effectiveness of a Mood Stabilizing Medication, an Antidepressant Medication, and a Combination of Both Medications to Treat Symptoms of Bipolar Type II Depression. http://www.clinicaltrials.gov/show/NCT00276965. Accessed February 2008.

<< Back